Srinagar, January 8: The Doctors Association Kashmir (DAK), under the leadership of its President, Dr. Yousuf Tak, has issued an advisory on Human Metapneumovirus (HMPV), a common respiratory virus that has been circulating globally since its discovery in the Netherlands in 2001.
In a press note released today, DAK emphasized that HMPV is not a new virus but a well-documented respiratory pathogen from the Pneumoviridae family, which includes the Respiratory Syncytial Virus (RSV). It typically causes symptoms similar to the common cold but can lead to severe infections, especially in young children, older adults, and those with weakened immune systems.
The symptoms of HMPV include runny or stuffy nose, cough, fever, sore throat, shortness of breath, wheezing, and rash. The virus spreads through direct contact, respiratory droplets from coughing or sneezing, and touching contaminated surfaces. The incubation period is 3 to 6 days, with illness lasting 2 to 7 days.
Dr. Tak stated that while HMPV is diagnosed based on symptoms and confirmed through molecular tests like RT-PCR, there is no specific antiviral treatment available. Supportive care is the primary approach, and antibiotics are not effective unless secondary bacterial infections are present.
The DAK spokesperson, Dr. Rubeena Bhat, outlined key preventive measures, including frequent handwashing with soap and water, avoiding close contact with sick individuals, covering the mouth and nose while sneezing or coughing, maintaining proper ventilation in public spaces, and staying home when unwell. She also cautioned against self-medication and highlighted the importance of seeking immediate medical care for high fever, difficulty breathing, or worsening pre-existing health conditions.
Dr. Tak urged the public to remain vigilant during respiratory illness outbreaks. “Adopting simple preventive measures can significantly reduce the risk of infection. Let us work together to maintain good hygiene and safeguard our community,” he said.
The DAK reminded the public that there is currently no vaccine available for HMPV, making preventive measures crucial in mitigating its spread.
